Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Douglas Teixeira Leffa, MD, PhD

Douglas Teixeira Leffa, MD, PhD

Dr Leffa is a psychiatry resident at the University of Pittsburgh Medical Center.

Articles by Douglas Teixeira Leffa, MD, PhD

Psychiatric Times with heart

What We Love About Psychiatry: Reflections From the Field

ByJohn J. Miller, MD,Allison S. Baker, MD,Douglas Teixeira Leffa, MD, PhD,Timothy Wilens, MD,Benjamin E. Yerys, PhD,Jennie Byrne, MD, PhD,Elysia Davis, PhD,Benjamin Hankin, PhD,Gary W. Small, MD

February 14th 2026

Adult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis

ByDouglas Teixeira Leffa, MD, PhD,Heidi Anne Duerr, MPH

January 22nd 2026

Douglas Leffa, MD, PhD, shares highlights from a poster at the APSARD conference examining severity and age of diagnosis.

Latest Updated Articles

Trending on Psychiatric Times

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

A Practical Role for Long-Acting Buprenorphine in Opioid Use Disorder Care

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

Kratom Component in Clinical Trial for Opioid Use Disorder

Objective Measurement for Psychiatry: Universal Brain's ERP System